Literature DB >> 17559229

Electron transfer reaction mechanism of cisplatin with DNA at the molecular level.

Q-B Lu1, S Kalantari, C-R Wang.   

Abstract

The cytotoxicity of cisplatin as a very effective chemotherapeutic anticancer drug is known to arise from its capacity to damage DNA. However, the mechanism of action of cisplatin at the molecular level, in particular, the reaction dynamics of cisplatin with DNA, remains elusive, and the reason why cisplatin binds to the guanine bases rather than to S-donor ligands available in cells remains a mystery. Using time-resolved femtosecond laser spectroscopy, for the first time, we reveal the high reactivity of cisplatin with electrons and its preferential electron-transfer reaction with the DNA guanine base. The results not only provide a molecular mechanistic understanding of cisplatin in cancer therapy but may have far-reaching significance for understanding the role of polar molecules such as NH3 and NH2 in biological reactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559229     DOI: 10.1021/mp070040a

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  16 in total

1.  In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.

Authors:  Michael Frezza; Q Ping Dou; Yan Xiao; Hamidreza Samouei; Mehdi Rashidi; Fayezeh Samari; Bahram Hemmateenejad
Journal:  J Med Chem       Date:  2011-08-24       Impact factor: 7.446

2.  Hydrated electrons react with high specificity with cisplatin bound to single-stranded DNA.

Authors:  B Behmand; P Cloutier; S Girouard; J R Wagner; L Sanche; D J Hunting
Journal:  J Phys Chem B       Date:  2013-12-10       Impact factor: 2.991

3.  Biological chemistry: Beyond radical thinking.

Authors:  Léon Sanche
Journal:  Nature       Date:  2009-09-17       Impact factor: 49.962

4.  Non-empirical quantum chemical studies on electron transfer reactions in trans- and cis-diamminedichloroplatinum(II) complexes.

Authors:  Janina Kuduk-Jaworska; Henryk Chojnacki; Jerzy J Jański
Journal:  J Mol Model       Date:  2011-05-11       Impact factor: 1.810

5.  Direct observation of ultrafast-electron-transfer reactions unravels high effectiveness of reductive DNA damage.

Authors:  Jenny Nguyen; Yuhan Ma; Ting Luo; Robert G Bristow; David A Jaffray; Qing-Bin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

6.  Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management.

Authors:  Janaina Fernandes; Gisele Cardoso de Amorim; Tallita Eduarda da Veiga; Jesiel Cardoso; Alberto Cardoso Arruda; Mara Silvia Pinheiro Arruda; Morgana T L Castelo-Branco
Journal:  J Biol Inorg Chem       Date:  2019-04-27       Impact factor: 3.358

7.  Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers.

Authors:  Ting Luo; Jianqing Yu; Jenny Nguyen; Chun-Rong Wang; Robert G Bristow; David A Jaffray; Xiao Zhen Zhou; Kun Ping Lu; Qing-Bin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

8.  New insights into the mechanism underlying the synergistic action of ionizing radiation with platinum chemotherapeutic drugs: the role of low-energy electrons.

Authors:  Mohammad Rezaee; Darel John Hunting; Léon Sanche
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-01       Impact factor: 7.038

9.  In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer.

Authors:  Xiaomeng Zhang; Huanjun Yang; Ke Gu; Jian Chen; Mengjie Rui; Guo-Liang Jiang
Journal:  Int J Nanomedicine       Date:  2011-02-21

Review 10.  Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments.

Authors:  Damiano Cirri; Francesco Bartoli; Alessandro Pratesi; Emma Baglini; Elisabetta Barresi; Tiziano Marzo
Journal:  Biomedicines       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.